Mead, Gillian E,
Sposato, Luciano A,
Sampaio Silva, Gisele,
Yperzeele, Laetitia,
Wu, Simiao,
Kutlubaev, Mansur,
Cheyne, Joshua,
Wahab, Kolawole,
Urrutia, Victor C,
Sharma, Vijay K,
Sylaja, PN,
Hill, Kelvin,
Steiner, Thorsten,
David S, Liebeskind,
Rabinstein, lejandro A (2023) , intracranial atherosclerotic disease, and antithrombotics in non-cardioembolic
stroke. For
rehabilitationChu, Shuk Han,
Zhao, Xu,
Komber, Ahmad,
Cheyne, Joshua,
Wu, Simiao,
Cowey, Eileen,
Kutlubaev, Mansur,
Mead, Gillian (2023) Background:
Post-stroke fatigue (PSF) affects around 50% of
stroke survivors. Previous systematic
MEAD, G.E.,
LEGG, L.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.,
DENNIS, M.S.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J. (2020) Objective: To determine whether fluoxetine, at any dose, given within the first year after
strokeCardioembolic ischemic
stroke (CIS) accounts 30-40% of all
stroke cases, characterized
ФАКТОРЫ, ВЛИЯЮЩИЕ НА ЭФФЕКТИВНОСТЬ РЕАБИЛИТАЦИИ БОЛЬНЫХ В ОСТРОМ ПЕРИОДЕ ЦЕРЕБРАЛЬНОГО ИНСУЛЬТАFACTORS AFFECTING THE EFFECTIVENESS OF
REHABILITATION IN PATIENTS IN THE ACUTE PERIOD OF CEREBRAL